Takeaways: XORTX’s planned Canadian CTA could strengthen XORLO’s regulatory pathway while generating clinical evidence to support a future U.S. NDA. The proprietary oxypurinol formulation ...
Takeaways: Health Canada’s approval of Dawnzera (donidalorsen) gives CELYSTRA a first‑in‑class, RNA‑targeted prophylaxis for hereditary angioedema (HAE) in patients ≥12 years, with Q4W/Q8W...
Takeaways: Completing pCPA negotiations is a key step toward public reimbursement for Nemluvio in Canada, which—once provincial/territorial drug plans list it—should materially expand access for...
Pfizer and BioNTech Receive Health Canada Authorization for XFG-Adapted Comirnaty Pfizer and BioNTech received Health Canada authorization for their XFG variant-adapted Comirnaty COVID-19 vaccine for ...
Takeaways: The Canadian approval expands Epkinly into a second major lymphoma indication (after DLBCL), giving AbbVie a bispecific‑based triplet option in relapsed/refractory follicular ly...
Abbott’s Volt PFA System Debuts in Canada Abbott announced the first Canadian use of its Volt Pulsed Field Ablation (PFA) System at McGill University Health Centre in Montreal to treat patients with a...
Takeaways: Health Canada’s authorization of the XFG‑adapted Comirnaty vaccine for the 2026–2027 season keeps Pfizer/BioNTech aligned with national recommendations to match contemporary Omicron l...
Takeaways: Sandoz Canada’s Health Canada authorization for PrSandoz Semaglutide, a generic version of Ozempic, gives the country its first lower‑cost semaglutide option for type 2 diabetes...
Takeaways: Optimi Health’s plan to start a Health Canada‑authorized Phase 3 trial of synthetic MDMA‑assisted therapy for PTSD in 2027 positions the company to potentially become an early mover i...
Takeaways: Health Canada’s acceptance of Knight Therapeutics’ New Drug Submission for Gemtesa (vibegron) moves the therapy closer to potential approval in Canada for adults with overactive bladd...
